
About Artroa

Eva Skiöldebrand -
Founder of biomarkers and pharmaceutical



Anders Lindahl -
Founder of biomarkers and pharmaceutical
Stina Ekman -
Founder of biomarkers
Elisabeth Hansson -
Founder of pharmaceutical
Eva Skiöldebrand is a veterinarian
and professor at the Swedish
University of Agricultural Sciences in
Uppsala. Her research area primarily
focuses on osteoarthritis, with a
particular emphasis on biomarkers
for diagnosis and drug development
in horses. Her work also adopts a
translational perspective, aiming to
apply the findings to human
medicine.With a substantial
background in the pharmaceutical
industry her expertise spans both
veterinary and human medicine,
making her research impactful and
relevant to both fields.
​
Foto: Addlight/Göran Ekeberg
Professor in clinical chemistry and transfusion-medicine at Gothenburg University. He is chief doctor specialized in clinical chemistry and cell-therapy, and has been COO at Sahlgrenska University Hospital for over 10 years. He is the founder of Cell Matrix AB and co-founder of Cellartis AB.
Professor in special pathology at the Swedish University of Agricultural Sciences. She is a Diplomate of ECVP and her expertise is in pathology of the locomotor system, with focus on osteoarthritis and osteochondrosis in domestic animals. She has a vast experience in different morphologic techniques.
​
Foto: Addlight/Göran Ekeberg
Professor in neurobiology at the Sahlgrenska Academy, University of Gothenburg. She is doing research on pharmacological substances in network coupled cells, the supporting cells in different organs in the body. These networks can be affected by inflammatory stimuli and become dysregulated. It can give rise to systemic inflammation, which in turn can lead to pain that can turn into chronic.
Founder and owner of the treatment drug.

Joakim Jehlbo -
VP Commercial development

Kristin Abrahamsson Aurell -
Founder of pharmaceutical

Viveka Sernvi Hansson -
Board member
Sporthorse veterinarian since 1996, specializing in orthopedics and surgery. Head of a equine clinic at Kungsbacka, Sweden
Founder and owner of the treatment drug


Joakim Jehlbo is a Swedish business executive with over 30 years of international experience in the pharmaceutical and medical technology industries. He has held leadership roles at prominent companies such as Pfizer, MSD, AstraZeneca, and BoneSupport. His career has spanned regions including the Middle East, Japan, the UK, North Africa, and Denmark, where he managed clinical trials, product launches, regulatory strategies, and led sales and marketing teams. In June 2023, Jehlbo joined SmiLe Incubator as a coach to support emerging companies with his extensive expertise and global network. He also serves as Vice President of Commercial Operations at Uman Sense, a medtech innovation company. Jehlbo holds a degree in strategy and leadership from the Military Academy Karlberg and a master's in General Management from INSEAD.
Johan Hammersberg -
MSc in Technology, PhD in Technology, Associate
Professor
Johan Hammersberg is an Associate Professor with a distinguished career in semiconductor physics and electronic devices. Over the past 25 years, he has transitioned from academia to industry, where he has excelled in research and product development of electronic devices and sensors across various companies.
Johan brings substantial technical expertise, spanning from product research to the industrialization and high-volume production of electronic devices. Recently, his focus has shifted towards technology and business development in the health and wellness sector.
Magnus Karlsteen -
Associate Professor at Chalmers University of Technology
Ph.D. in electronic components, is active in sports and technology development. As the Project Leader for the National Sports University (RIU) at Chalmers, he guides initiatives at the intersection of sports, technology, and academia. His diverse contributions extend to Equine Science, emphasizing his pivotal role in advancing innovation at the convergence of disciplines. His research spans from AI-driven dental manufacturing to innovative work on the use of biomarkers for arthrosis. In essence, he plays a crucial role in propelling innovation in dynamic intersections.
​Viveka Sernvi Hansson is a Senior Innovation & Business Advisor at SLU Holding AB, where she plays a pivotal role in bridging research and societal applications. With a Master of Science in Mechanical Engineering, she brings a robust technical foundation to her advisory position.In her capacity at SLU Holding, Viveka has been instrumental in initiatives such as the Plant Protein Factory at SLU Alnarp, aiming to transform agricultural residues into valuable plant proteins for diverse applications. She emphasizes the importance of early-stage collaboration with researchers to foster innovation, encouraging them to engage with SLU Holding to develop their ideas under confidentiality. Viveka's expertise extends to deep tech, recognizing SLU's potential to contribute groundbreaking research in this area. She advocates for interdisciplinary collaboration to address complex societal challenges, aligning with agencies like Vinnova to advance deep tech initiatives. Her combined engineering background and commitment to innovation position her as a key figure in translating scientific research into practical, impactful solutions.
Board members of Artroa AB and SGPTH Life Science AB
Artroa AB

Elisabeth Hansson: Founder and board member. A professor of neurobiology at the Sahlgrenska Academy, University of Gothenburg. Her research focuses on pharmacological substances in network-connected cells and support cells in various organs of the body.

Anders Lindahl: Founder and board member. A professor of clinical chemistry and transfusion medicine at the University of Gothenburg. He is a specialist in clinical chemistry and cell therapy, having served as COO at Sahlgrenska University Hospital for over 10 years. He is the founder of Cell Matrix AB and co-founder of Cellartis AB.

Kristin Abrahamsson Aurell. Founder and board member. A veterinarian specializing in equine medicine and the clinic director at Kungsbacka Equine Clinic.

Eva Skiöldebrand. Founder and chairperson of the board. A professor of general pathology at the Swedish University of Agricultural Sciences (SLU). Her research focuses on osteoarthritis and other joint-related conditions, with strong clinical connections in veterinary medicine.

Viveka Sernvi Hansson. Board member. Senior Advisor at SLU Holding AB with a Master’s degree in Mechanical Engineering. She brings significant expertise in innovation and business development.
SGPTH Life Science AB

Stina Ekman Board member. A professor of special pathology at SLU and an ECVP diplomat. Her expertise lies in the pathology of the musculoskeletal system, focusing on osteoarthritis and osteochondrosis in domestic animals.
Anders Lindahl: Board member. See above for details.
​
Viveka Sernvi Hansson: Board member. See above for details.
Eva Skiöldebrand: Chairperson of the board. See above for details.